Geng An Feng - Net Worth and Insider Trading

Geng An Feng Net Worth

The estimated net worth of Geng An Feng is at least $5 Million dollars as of 2025-07-24. Geng An Feng is the senior management of Cabio Biotech (Wuhan) Co Ltd and owns about 165,746 shares of Cabio Biotech (Wuhan) Co Ltd (SHSE:688089) stock worth over $5 Million. Details can be seen in Geng An Feng's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Geng An Feng has not made any transactions after 2024-02-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Geng An Feng

To

Geng An Feng Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Geng An Feng owns 1 companies in total, including Cabio Biotech (Wuhan) Co Ltd (SHSE:688089) .

Click here to see the complete history of Geng An Feng’s form 4 insider trades.

Insider Ownership Summary of Geng An Feng

Ticker Company Transaction Date Type of Owner
SHSE:688089 Cabio Biotech (Wuhan) Co Ltd 2024-02-06 senior management

Geng An Feng Latest Holdings Summary

Geng An Feng currently owns a total of 1 stock. Geng An Feng owns 165,746 shares of Cabio Biotech (Wuhan) Co Ltd (SHSE:688089) as of February 6, 2024, with a value of $5 Million.

Latest Holdings of Geng An Feng

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SHSE:688089 Cabio Biotech (Wuhan) Co Ltd 2024-02-06 165,746 27.40 4,541,440

Holding Weightings of Geng An Feng


Geng An Feng Form 4 Trading Tracker

According to the SEC Form 4 filings, Geng An Feng has made a total of 11 transactions in Cabio Biotech (Wuhan) Co Ltd (SHSE:688089) over the past 5 years, including 7 buys and 3 sells. The most-recent trade in Cabio Biotech (Wuhan) Co Ltd is the acquisition of 9,400 shares on February 6, 2024, which cost Geng An Feng around $99,161.

Insider Trading History of Geng An Feng

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Geng An Feng Trading Performance

GuruFocus tracks the stock performance after each of Geng An Feng's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Geng An Feng is 7.31%. GuruFocus also compares Geng An Feng's trading performance to market benchmark return within the same time period. The performance of stocks bought by Geng An Feng within 3 months outperforms 2 times out of 7 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Geng An Feng's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Geng An Feng

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
6 out of 7 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -2.2 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -3.86 LIMIT LIMIT LIMIT LIMIT LIMIT

Geng An Feng Ownership Network

Ownership Network List of Geng An Feng

No Data

Ownership Network Relation of Geng An Feng

Insider Network Chart


Geng An Feng Owned Company Details

What does Cabio Biotech (Wuhan) Co Ltd do?

Who are the key executives at Cabio Biotech (Wuhan) Co Ltd?

Geng An Feng is the senior management of Cabio Biotech (Wuhan) Co Ltd. Other key executives at Cabio Biotech (Wuhan) Co Ltd include Core technical personnel Shang Yun , senior management Xiao Min , and Directors & senior managers Wang Hua Biao .

Cabio Biotech (Wuhan) Co Ltd (SHSE:688089) Insider Trades Summary

Over the past 18 months, Geng An Feng made 2 insider transaction in Cabio Biotech (Wuhan) Co Ltd (SHSE:688089) with a net purchase of 20,136. Other recent insider transactions involving Cabio Biotech (Wuhan) Co Ltd (SHSE:688089) include a net sale of 24,080 shares made by Shang Yun , a net sale of 25,800 shares made by Xiao Min , and a net purchase of 20,000 shares made by Du Bin .

In summary, during the past 3 months, insiders sold 22,080 shares of Cabio Biotech (Wuhan) Co Ltd (SHSE:688089) in total and bought 0 shares, with a net sale of 22,080 shares. During the past 18 months, 53,880 shares of Cabio Biotech (Wuhan) Co Ltd (SHSE:688089) were sold and 63,108 shares were bought by its insiders, resulting in a net purchase of 9,228 shares.

Cabio Biotech (Wuhan) Co Ltd (SHSE:688089)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Cabio Biotech (Wuhan) Co Ltd Insider Transactions

No Available Data

Geng An Feng Mailing Address

Above is the net worth, insider trading, and ownership report for Geng An Feng. Currently GuruFocus does not have mailing address information for Geng An Feng.